Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration
Journal of Clinical Medicine · 06.08.2023 · 12 (15) · 5145
DOI: 10.3390/jcm12155145 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 06.08.2023. Verfasst von Maya Kishi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 12 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
To evaluate the functional and anatomical effects of switching to faricimab for patients with neovascular age-related macular degeneration (nAMD) refractory to intravitreal aflibercept, this retrospective study evaluated patients with nAMD who received intravitreal injections of aflibercept (IVA) every
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Surgery, Division of Ophthalmology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan.
ORCID-Profile: Akiko Miki, Hisanori Imai, Sentaro Kusuhara, Makoto Nakamura
Zitieren
APA
Kishi, M., Miki, A., Kamimura, A., Okuda, M., Matsumiya, W., Imai, H., Kusuhara, S., & Nakamura, M. (2023). Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine, 12(15), 5145. https://doi.org/10.3390/jcm12155145
Vancouver
Kishi M, Miki A, Kamimura A, Okuda M, Matsumiya W, Imai H, et al. Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration. Journal of Clinical Medicine. 2023;12(15):5145. doi:10.3390/jcm12155145
BibTeX
@article{Kishi2023,
author = {Kishi, Maya and Miki, Akiko and Kamimura, Aya and Okuda, Mina and Matsumiya, Wataru and Imai, Hisanori and Kusuhara, Sentaro and Nakamura, Makoto},
title = {Short-Term Outcomes of Faricimab Treatment in Aflibercept-Refractory Eyes with Neovascular Age-Related Macular Degeneration},
journal = {Journal of Clinical Medicine},
year = {2023},
volume = {12},
number = {15},
pages = {5145},
doi = {10.3390/jcm12155145}
}
EUVIMED